Geriatric Syndrome in Nursing Home Residents

June 10, 2025 updated by: Ulkukezbansahin, Giresun University

Predictors of the Disability in Nursing Home Residents: a Descriptive Study

Disability in daily living activities (ADL) is a typical issue among nursing care residents. The goal of this study was to look at the geriatric syndromes that cause incapacity in nursing home residents.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

More often than not, people who live in nursing homes can't move out. One of the main reasons they leave their own home is to lose their freedom. Nursing homes also have a lot of people with geriatric diseases like cognitive impairment, balance problems, urinary incontinence, and disability. But it's not known what role geriatric syndromes play in ADL impairment. To come up with good ways to treat geriatric syndromes, which are the main causes of ADL disability in nursing home patients, we need to know more about them. So, the point of this study was to look into geriatric syndromes that are linked to disability and find out what causes disability in nursing home patients.

Study Type

Observational

Enrollment (Actual)

124

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Giresun, Turkey, 28000
        • Giresun University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

This cross-sectional study was conducted in nursing homes located in two cities.

Description

Inclusion Criteria:

  • age over 65
  • staying in a nursing home for at least 12 months
  • consent to participate in the study were the inclusion criteria.

Exclusion Criteria:

  • people who were mentally unable to answer questions,
  • people who were hospitalized
  • people who had severe hearing or vision problems that made it hard to communicate
  • people who took benzodiazepines or psychotropic drugs that made it hard to walk or balance
  • people who had fractures or endoprostheses in any part of their bodies.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
frailty
Time Frame: 5 minute

FRAIL includes five items that evaluate ambulation, weight loss, fatigue, diseases, and resistance.

Each item receives a value of 0 or 1, for a total score ranging from 0 (best) to 5 (worst). A score of 3 shows frailty, a score of 1-2 indicates prefrailty, and a score of 0 indicates robustness.
5 minute
disability
Time Frame: 5 minute
The Barthel Index (BI) was used to determine the level of disability in ADL. The indicator has a maximum total score of 100, indicating that the individual is entirely autonomous in all physical functions. The lowest possible score is 0; this indicates that the individual is entirely dependent.
5 minute

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sarcopenia
Time Frame: 5 minute
The SARC-F questionnaire was used to assess the risk of sarcopenia. The indicator has a maximum total score of 100, indicating that the individual is entirely autonomous in all physical functions. The lowest possible score is 0; this indicates that the individual is entirely dependent.
5 minute

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Giresun University

Investigators

  • Principal Investigator: ULKU K SAHIN, PhD, Giresun University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2022

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

April 25, 2023

Study Registration Dates

First Submitted

October 9, 2023

First Submitted That Met QC Criteria

October 9, 2023

First Posted (Actual)

October 13, 2023

Study Record Updates

Last Update Posted (Actual)

June 13, 2025

Last Update Submitted That Met QC Criteria

June 10, 2025

Last Verified

October 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Nursing home

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The datasets generated during and analyzed during the current study are available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disability Physical

Clinical Trials on Diagnostic test

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe